Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune stimulation and HIV-1 viral replication

S M Wahl1, J M Orenstein

  • 1Oral Infection and Immunity Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892-4352, USA.

Journal of Leukocyte Biology
|July 1, 1997
PubMed
Summary

HIV-1 infection causes two main viremia peaks. Immune challenges like infections can trigger temporary viral increases, with tissue macrophages becoming key producers as CD4+ T cells decline.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jupiter's atmospheric jet streams extend thousands of kilometres deep.

Nature·2018
Same author

A suppression of differential rotation in Jupiter's deep interior.

Nature·2018
Same author

CD84 is markedly up-regulated in Kawasaki disease arteriopathy.

Clinical and experimental immunology·2014
Same author

HIV infection and specific mucosal immunity: workshop 4B.

Advances in dental research·2011
Same author

Intestinal macrophages and response to microbial encroachment.

Mucosal immunology·2010
Same author

Measurement of TGF-beta in biological fluids.

Current protocols in immunology·2008

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) infection is characterized by biphasic viremia.
  • Early viremia occurs before the host immune response, while a late peak coincides with immune system decline.
  • Intermittent viremia episodes are linked to immune challenges, including vaccinations and infections.

Purpose of the Study:

  • To investigate the source of viral replication during different stages of HIV-1 infection.
  • To understand the transition in HIV-1 production from CD4+ T lymphocytes to tissue macrophages.
  • To identify mechanisms for therapeutic control of HIV-1 and opportunistic infections.

Main Methods:

  • Observational study analyzing viremia patterns in HIV-1-infected individuals.
  • Assessment of viral burden in relation to immune status (CD4+ T cell counts).
  • Identification of viral production sites, particularly macrophages in co-infected tissues.

Main Results:

  • HIV-1 exhibits distinct early and late viremia phases.
  • Immune challenges reversibly increase viral load, dependent on CD4+ T cell levels.
  • Opportunistic infections trigger viremia even with low CD4+ T cell counts.
  • Tissue macrophages co-infected with opportunistic pathogens are significant HIV-1 producers.

Conclusions:

  • The primary source of HIV-1 shifts from CD4+ T lymphocytes to tissue macrophages as the disease progresses and CD4+ T cells are depleted.
  • Understanding this transition is crucial for managing opportunistic infections and controlling HIV-1.
  • Further research into these mechanisms could lead to improved therapeutic strategies.

Related Experiment Videos